Inventor · disambiguated record
Chiajen Lai
Also filed as: LAI CHIAJEN
17 granted patents·11 pending applications·237 citations·filing 2003–2024
93Inventor score
Files withBRISTOL MYERS SQUIBB CO10GILEAD SCIENCES INC10KRONOS BIO INC3ASTRAZENECA AB2GOUGOUTAS JACK Z1
Top patents by PatentIndex Score
28 records- 0195US7375213B2Methods of producing C-aryl glucoside SGLT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 20, 2008·123 cites·21 claims
- 0293US11613553B2Methods of preparing 1′-cyano nucleosidesGILEAD SCIENCES INC·Filed 2021·Granted Mar 28, 2023·19 cites·12 claims
- 0393US7919598B2Crystal structures of SGLT2 inhibitors and processes for preparing sameBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Apr 5, 2011·51 cites·15 claims
- 0491US7932379B2Methods of producing C-aryl glucoside SGLT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Apr 26, 2011·26 cites·13 claims
- 0585US12152037B2Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitorKRONOS BIO INC·Filed 2022·Granted Nov 26, 2024·1 cites·7 claims
- 0684US11440928B2Crystalline forms of tenofovir alafenamideGILEAD SCIENCES INC·Filed 2019·Granted Sep 13, 2022·1 cites·22 claims
- 0782US10287307B2Crystalline forms of tenofovir alafenamideGILEAD SCIENCES INC·Filed 2018·Granted May 14, 2019·2 cites·22 claims
- 0882US2025215031A1Crystalline forms of tenofovir alafenamideGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 0979US12202849B2Crystalline forms of tenofovir alafenamideGILEAD SCIENCES INC·Filed 2022·Granted Jan 21, 2025·0 cites·22 claims
- 1079US11339168B2Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitorsKRONOS BIO INC·Filed 2020·Granted May 24, 2022·1 cites·4 claims
- 1179US8501698B2Crystal structures of SGLT2 inhibitors and processes for preparing sameGOUGOUTAS JACK Z·Filed 2011·Granted Aug 6, 2013·5 cites·29 claims
- 1279US2024409575A1Methods of preparing 1'-cyano nucleosidesGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1376US7601715B2Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced thereinBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Oct 13, 2009·4 cites·12 claims
- 1475US9453039B2Crystal structures of SGLT2 inhibitors and processes for preparing sameASTRAZENECA AB·Filed 2013·Granted Sep 27, 2016·2 cites·7 claims
- 1574US2025313566A1CRYSTALLINE FORMS OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZO[l,2-a]PYRAZIN-8-AMINE AS SYK INHIBITORSKRONOS BIO INC·Filed 2024·Application pending·0 cites
- 1669US7671199B2Process for the preparation of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2, 1-F][1,2,4]triazin-6-yloxy]-1-methylethyl esterBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 2, 2010·2 cites·16 claims
- 1764US2024043466A1Solid forms of a nucleoside analogue and uses thereofGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 1863US2024051962A1Solid forms of a nucleoside analogue and uses thereofGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 1962US2014243517A1Methods of producing c-aryl glucoside sglt2 inhibitorsASTRAZENECA AB·Filed 2014·Application pending·0 cites
- 2060US7820820B2Method of preparation of azaindole derivativesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Oct 26, 2010·0 cites·3 claims
- 2158US7968718B2Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced thereinBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jun 28, 2011·0 cites·1 claims
- 2256US10407438B2Crystalline forms of darunavirGILEAD SCIENCES INC·Filed 2017·Granted Sep 10, 2019·0 cites·13 claims
- 2354US7598380B2Method of preparation of azaindole derivativesBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Oct 6, 2009·0 cites·15 claims
- 2454US2011201795A1Methods of Producing C-Aryl Glucoside SGLT2 InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2011·Application pending·0 cites
- 2550US2010292246A1Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1h-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dioneBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 2648US2006100209A1Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dioneGU CHONG-HUI·Filed 2005·Application pending·0 cites
- 2740US2006128726A1Process for preparing novel crystalline forms of (2S)-1-[[(7R)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyrimidine-6-yl]carbonyl]-2-(4-fluorophenyl)pyrrolidine, novel stable forms produced therein and formulationsWANG XUEBAO·Filed 2005·Application pending·0 cites
- 2837US2017217952A1Crystalline formGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chiajen Lai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →